[CAS NO. 490-46-0]  (-)Epicatechin

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [490-46-0]

Catalog
SLK-S4723
Brand
Selleck
CAS
490-46-0

DESCRIPTION [490-46-0]

Overview

MDLMFCD00075648
Molecular Weight290.27
Molecular FormulaC15H14O6
SMILESO[C@H]1[C@H](OC=2C(C1)=C(O)C=C(O)C2)C3=CC(O)=C(O)C=C3

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM3.4451 mL17.2253 mL34.4507 mL
5 mM0.6890 mL3.4451 mL6.8901 mL
10 mM0.3445 mL1.7225 mL3.4451 mL
50 mM0.0689 mL0.3445 mL0.6890 mL

Description

(−)Epicatechin (L-Epicatechin, (-)-Epicatechol) is a flavonoid present in cocoa, green tea and red wine. It is a strong antioxidant, has insulin mimic action and improves heart health., (−)Epicatechin (L-Epicatechin, (-)-Epicatechol)是一种类黄酮,在可可、绿茶、红酒中常见。具有强的抗氧化、胰岛素类似作用,能改善心脏健康。

In vitro

(-)-Epicatechin stimulates mitochondrial respiration and oxygen consumption in Panc-1 cells. Human normal fibroblasts are not affected. (-)-Epicatechin sensitizes Panc-1, U87, and MIA PaCa-2 cells with an average radiation enhancement factor (REF) of 1.7, 1.5, and 1.2, respectively. (-)-Epicatechin does not sensitize normal fibroblast cells to ionizing radiation with a REF of 0.9, suggesting cancer cell selectivity. (-)-Epicatechin enhances Chk2 phosphorylation and p21 induction when combined with radiation in cancer, but not normal cells.

In vivo

Aging has deleterious effects on modulators of muscle growth/differentiation, the consumption of modest amounts of the flavanol (−)-epicatechin can partially reverse these changes. In mice, myostatin and senescence-associated β-galactosidase levels increase with aging, while those of follistatin and Myf5 decrease. (−)-Epicatechin decreases myostatin and β-galactosidase and increases levels of markers of muscle growth. In humans, myostatin and β-galactosidase increase with aging while follistatin, MyoD and myogenin decrease. Treatment for 7 days with (−)-epicatechin increases hand grip strength and the ratio of plasma follistatin/myostatin. Low-dose (−)-epicatechin treatment resulted in significant increases in skeletal muscle capillarity, mitochondrial biogenesis, and oxidative enzyme activity, which corresponded to lower muscle fatigue and higher endurance capacity when compared to the placebo group. (−)-epicatechin may potentially regulate the protein expression between angiogenic and antiangiogenic factors, such as VEGF-A and TSP-1, respectively.


Synonyms

2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R,3R)-
Epicatechol, (-)-
2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R-cis)-
(2R,3R)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol
(-)-Epicatechin
(-)-Epicatechol
(-)-(2R:3R)-5,7,3′,4′-Tetrahydroxyflavan-3-ol
Epicatechin
epi-Catechol
l-Epicatechin
l-Epicatechol
Epicatechol
(2R,3R)-(-)-Epicatechin
epi-Catechin
l-Acacatechin
L-Epicatechin
NSC 81161
(-)-epi-Catechin